Followers | 11 |
Posts | 1500 |
Boards Moderated | 0 |
Alias Born | 04/18/2016 |
Monday, June 27, 2022 9:26:39 AM
Recent CYTO News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/04/2024 08:01:02 PM
- Altamira Therapeutics Provides Update on Nasdaq Listing • GlobeNewswire Inc. • 10/04/2024 08:01:00 PM
- Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray • GlobeNewswire Inc. • 09/27/2024 01:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/24/2024 12:15:21 PM
- Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results • GlobeNewswire Inc. • 09/24/2024 12:01:00 PM
- Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024 • GlobeNewswire Inc. • 09/20/2024 01:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/19/2024 08:17:07 PM
- Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering • GlobeNewswire Inc. • 09/19/2024 08:01:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/18/2024 08:19:22 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/18/2024 04:15:12 AM
- Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering • GlobeNewswire Inc. • 09/17/2024 09:00:00 PM
- Form F-1/A - Registration statement for certain foreign private issuers: [Amend] • Edgar (US Regulatory) • 09/16/2024 05:55:02 PM
- Form F-1/A - Registration statement for certain foreign private issuers: [Amend] • Edgar (US Regulatory) • 09/16/2024 01:29:34 PM
- Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia • GlobeNewswire Inc. • 09/16/2024 12:30:00 PM
- Altamira Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 9-11 • GlobeNewswire Inc. • 09/03/2024 01:01:00 PM
- Altamira Therapeutics Announces Extension of Bentrio Distribution Agreement with Pharma Nordic to Include Sweden and Denmark • GlobeNewswire Inc. • 08/23/2024 01:01:00 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 08/22/2024 08:53:27 PM
- Altamira Therapeutics Announces Confirmed Suitability of Bentrio for Athletes as Comprehensive Testing Shows Absence of Prohibited Substances • GlobeNewswire Inc. • 08/16/2024 01:01:00 PM
- Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in Combination with Zbtb46 mRNA Delivered with SemaPhore Nanoparticles in Animal Tumor Models • GlobeNewswire Inc. • 08/12/2024 01:02:00 PM
- Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles • GlobeNewswire Inc. • 07/19/2024 01:01:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/08/2024 09:17:01 PM
- Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management • GlobeNewswire Inc. • 06/20/2024 01:01:00 PM
- Altamira Therapeutics Provides Business Update • GlobeNewswire Inc. • 05/28/2024 02:31:08 PM
- Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal • GlobeNewswire Inc. • 05/23/2024 12:47:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM